Brillient has been awarded a 1-year, $1.7M task from the Food and Drug Administration to provide Oncology Center of Excellence (OCE) professional and technical services. This task was awarded as an 8(a) competed set-aside action using the Professional and Technical Services BPA.
Awardee Name: BRILLIENT CORPORATION
Contract Duration: 12 months
Total Contract Value: $1,657,896.96
Funding Agency: FOOD AND DRUG ADMINISTRATION
Funding Office: HHS PHS FOOD AND DRUG ADMIN
Award ID: 75F40121F19177
Brillient was named to the list of NXT UP firms poised to make big waves in the Federal sector in 2020 and for years to come.
